204 related articles for article (PubMed ID: 4281637)
1. [Possibilities and limitations of immunosuppressive treatment].
Stobbe H
Allerg Immunol (Leipz); 1973; 19(2-4):363-79. PubMed ID: 4281637
[No Abstract] [Full Text] [Related]
2. [Practical use of immunosuppression].
Amiel JL
Munch Med Wochenschr; 1970 Mar; 112(12):497-500. PubMed ID: 4911634
[No Abstract] [Full Text] [Related]
3. [Bases of antilymphocytic globulin and its therapeutic possibilities].
Brendel W
Arzneimittelforschung; 1970 Feb; 20(2):191-7. PubMed ID: 4191782
[No Abstract] [Full Text] [Related]
4. [Immunosuppression].
Amiel JL
Minerva Med; 1970 Jul; 61(55):3022-7. PubMed ID: 5427676
[No Abstract] [Full Text] [Related]
5. [Immunosuppressive treatment and its side effects].
Scheiffarth F
Med Klin; 1971 Sep; 66(36):1183-9. PubMed ID: 4938064
[No Abstract] [Full Text] [Related]
6. [Immunodepression].
Amiel JL
Cah Med; 1970 May; 11(5):383-8. PubMed ID: 4912852
[No Abstract] [Full Text] [Related]
7. [Immunosuppression by means of antilymphocyte serums in humans].
Revillard JP
Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
[No Abstract] [Full Text] [Related]
8. "Spare parts" revisited.
Rapaport FT
Transplant Proc; 1975 Sep; 7(3):343-50. PubMed ID: 1099740
[No Abstract] [Full Text] [Related]
9. Synergism between cortisol and antilymphocyte serum. I. Observations in murine allograft systems.
Gunn A; Lance EM; Medawar PB; Nehlsen SL
Ciba Found Study Group; 1970; 36():66-72. PubMed ID: 4399436
[No Abstract] [Full Text] [Related]
10. Thoracic duct drainage as an aid for immunosuppression in human renal transplantation.
Murray JE; Birtch A; Wilson RE
Transplant Proc; 1972 Dec; 4(4):465 passim. PubMed ID: 4566787
[No Abstract] [Full Text] [Related]
11. [Study of the immunologic restoration of allogenic hematopoietic radiation chimeras].
Hrsak I; Nouza K; Kolar V; Mathé G
Rev Fr Etud Clin Biol; 1968 Nov; 13(9):887-93. PubMed ID: 4885128
[No Abstract] [Full Text] [Related]
12. Survey of the current status of the clinical uses of antilymphocyte serum.
Monaco AP; Codish SD
Surg Gynecol Obstet; 1976 Mar; 142(3):417-26. PubMed ID: 766248
[TBL] [Abstract][Full Text] [Related]
13. [Round-table discussion on immunosuppressive agents in ophthalmology].
Arch Ophtalmol Rev Gen Ophtalmol; 1972 Jan; 32(1):75-100. PubMed ID: 4261214
[No Abstract] [Full Text] [Related]
14. [What is certain in the treatment with immunosuppressive agents?].
Malchow H
Internist (Berl); 1971 Dec; 12(12):504-12. PubMed ID: 4944681
[No Abstract] [Full Text] [Related]
15. [Immune tolerance and antilymphocyte sera].
Kaden J
Z Arztl Fortbild (Jena); 1971 May; 65(9-10):522-8. PubMed ID: 5000438
[No Abstract] [Full Text] [Related]
16. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
[No Abstract] [Full Text] [Related]
17. In vivo evaluation of antihuman lymphocyte sera.
Balner H
Fed Proc; 1970; 29(1):117-9. PubMed ID: 4983811
[No Abstract] [Full Text] [Related]
18. Immunosuppression.
Parker CW; Vavra JD
Prog Hematol; 1969; 6():1-81. PubMed ID: 4181118
[No Abstract] [Full Text] [Related]
19. Immunosuppressive chemotherapy and malignancy.
Schwartz RS
Transplant Proc; 1974 Dec; 6(4 Suppl 1):45-8. PubMed ID: 4612903
[No Abstract] [Full Text] [Related]
20. The effects of hydrocortisone on the immune response.
Cohen JJ
Ann Allergy; 1971 Jul; 29(7):358-61. PubMed ID: 4398551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
